FY2009 First Quarter Financial Results. SUZUKI MOTOR CORPORATION August 3, 2009

Similar documents
Consolidated: Financial Summary

DELICA D:5 ACTIVE GEAR 0

Summary of Results for the First Half of FY2015/3

1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes

Hyundai Motor Company 1 st Quarter 2011 Business Results. April 28, 2011

Supplementary Data of Consolidated Financial Statements for the third quarter ended December 31, 2016

FY2007 Consolidated Financial Overview

Business Results. for the First Quarter of FY2016/3. August 4, 2015 (Tue.) NH Foods Ltd.

For personal use only

Forward Looking Information

1Q 2014 Earnings Release

Fiscal Year 2003 Consolidated 1 st Quarter Business Performance. Eisai Co., Ltd.

Korean Airlines Q Results

Third-quarter results 2013

Telekom Austria Group Results for the 1st Quarter May 27, 2003

Endesa 1Q 2017 Results 09/05/2017

Welcome to LG Electronics

Putting ALK on the right growth trajectory

Sumitomo Pharmaceuticals reaches a basic agreement to merge with Dainippon Pharmaceutical

Slide 1. Investor presentation. London 5 February 2019

APPLIANCE TELECOMMUNICATIONS

ELICA 2012 Q3 RESULTS. November 14,

Increase in revenues in line with full-year targets (+1.2%) Very strong growth of Oralair exc. USA (+26%) H revenues and results - 24 July 2014

Summary Statement of Financial Position (consolidated)

Results Briefing Junichi Yoshii President & Representative Director

2nd Quarter Financial Analyst Meeting

JT Reports Consolidated Financial Results For the Nine-Month Period that Ended December 31, 2007

Boiron Group confirms its forecasts for year 2008 : sales increase and growth in current operating income.

A world leader in allergy immunotherapy

THIRD QUARTER REPORT 2011 (UNAUDITED)

2nd Quarter Financial Analyst Meeting

For personal use only

2nd Quarter Financial Analyst Meeting

First Half Fiscal Year 2004 Financial Results. Eisai Co., Ltd.

Enhancing Corporate Value

Review of Half Year 2010

Eisai Co,. Ltd. and Merck & Co., Inc., Kenilworth, N.J., U.S.A.

Uroplasty, Inc. Investor Update Canaccord Genuity Conference December 6, 2011

CPH Chemie + Papier Holding AG. Investor Day. Perlen, 13 th September 2018

Economic Data LG Innotek Sustainability Report. Sales by Business Unit. Sales by Region. Optics Solution BU 2,980,322

Slide 1. Financial update and closing remarks. Jesper Brandgaard EVP and CFO. RAFAEL DE JESÚS FLORES, Mexico Rafael has haemophilia A

Results Briefing. 15 ~ 17 May 2007

ONO PHARMACEUTICAL CO., LTD.

METVIX PDT ON THE MARKET IN GERMANY AND UK

FY2016 1H Results. Cookpad Inc.

ONO PHARMACEUTICAL CO., LTD.

ASL MARINE. DBS Vickers Pulse of Asia Roadshow 10 January 2012

PATENCY-1 Top-Line Results

Coloplast A/S. Investor presentation 1H 2005/06

ADM to Acquire Neovia and Probiotics International Limited. July 2, 2018

Slide 1. International Operations update. Mike Doustdar EVP International Operations. YASMIN FIEDLER, Germany Yasmin has type 1 diabetes

Financial Presentation

Slide 1. Welcome and introduction. Lars Rebien Sørensen President & CEO

Efforts start to pay off in the fourth quarter

International Operations overview and strategy. Maziar Mike Doustdar EVP International Operations. Slide 1

Oral semaglutide and production expansion. Henrik Wulff EVP Product Supply. Peter Kristensen SVP Global Development

Investor Presentation

FIRST QUARTER 2018 RESULTS 15 MAY 2018 LUCA BETTONTE, CEO

ThromboGenics Business Update H1 2018

JT Group Consolidated Financial Results 2018 First Quarter Results

Dainippon Pharmaceutical and Sumitomo Pharmaceuticals Finalize Merger Agreement

Valneva Reports Strong Q1 Revenue Growth and Positive EBITDA Reaffirms Financial Guidance and Pipeline Outlook for 2017

Slide 1. Winning with GLP-1. Lars Fruergaard Jørgensen President and CEO. ALEXANDRE DE GREGORIO, Brazil Alexandre has type 2 diabetes

Third Quarter Consolidated Financial Results

Presentation of. Burgdorf, 1 st November 2012

2014 Full Year Results Presentation. Year ended 31 March 2014

REATA PHARMACEUTICALS, INC. ANNOUNCES SECOND QUARTER 2018 FINANCIAL RESULTS AND AN UPDATE ON DEVELOPMENT PROGRAMS

BANK HANDLOWY W WARSZAWIE S.A. 1Q 2009 consolidated financial results -1-

Acquisition of Novartis Influenza Vaccines Business. 27 th October 2014

Interim Financial Report First Half results 2011

Fujisawa Announce Financial Results for 1 st Quarter of FY 03/2005

Inflation projection of the National Bank of Poland based on the NECMOD model

Enel Américas 1Q 2018 results

Value creation through profitable growth Handelsbanken Nordic Large Cap Seminar, Stockholm 2016 Anders Lonning-Skovgaard, CFO

Woongjin Coway. 1Q 12 IR Presentation

Results Presentation 2Q FY March Win-Partners Co., Ltd. (3183)

Overview of consolidated results Main Product Sales Update Development pipelines. KYORIN Holdings, Inc.

Zealand Pharma A/S Interim report for Q (un-audited)

Annual General Meeting of Shareholders of Philip Morris ČR a.s. Kutná Hora April 25, András Tövisi Chairman of the Board of Directors

HALOZYME REPORTS SECOND QUARTER 2018 RESULTS

Walgreens (WAG) Analyst: Juan Fabres Fall 2014

MANAGEMENT. MGMT 0021 THE MANAGEMENT PROCESS 3 cr. MGMT 0022 FINANCIAL ACCOUNTING 3 cr. MGMT 0023 MANAGERIAL ACCOUNTING 3 cr.

Passion for progress, care for people

Q Investor Kit JANUARY-JUNE 2013

FY 2017 (Ended March 31, 2018) Full Year Financial Results. Reference Data. May 15, Eisai Co., Ltd.

Interim report Second quarter 2017 and subsequent events (Unaudited)

Full Year Update FY2011 May 2011

Coloplast A/S. Investor Presentation 2005/06

Boehringer Ingelheim and investment in R&D. Volker Barkmann

Shareholder Presentation Annual Meeting 2018

VITROLIFE AB (PUBL) Pareto Securities Health Care Conference

SPHERIX ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS

Q Investor Kit JANUARY-MARCH 2014

H. LUNDBECK A/S. Teleconference. 10 August PM CET. Financial results Second quarter 2011

Q Investor Kit January December 2014

Developing & Commercializing Targeted Small Molecule Drugs in Cancer

1 st Quarter of Fiscal 2015 Financial Results Conference Call. August 3, 2015

Q Investor Kit JANUARY-JUNE 2014

Fisher & Paykel Healthcare

Corporate Update Simon Hubbert, CEO Bill Kullback, CFO June, 2015

Transcription:

FY2009 First Quarter Financial Results SUZUKI MOTOR CORPORATION August 3, 2009

Consolidated: Financial Summary Page 2 FY2009 1Q FY2008 4Q 09/4-6 09/1-3 Change FY2008 1Q 08/4-6 Change (Billion Yen) (A) (B) (A)-(B) (C) (A)-(C) Net sales 577.1 670.1-93.0 910.4-333.3 Operating income (Ratio) 6.9 (1.2%) 10.4 (1.6%) -3.5 33.8 (3.7%) -26.9 Ordinary income (Ratio) 12.6 (2.2%) 8.2 (1.2%) +4.4 45.4 (5.0%) -32.8 Net income (Ratio) 2.1 (0.4%) 5.8 (0.9%) -3.7 26.0 (2.9%) -23.9

Consolidated: Net Sales Page 3 Domestic production Domestic sales 910.4 Domestic production Overseas sales Overseas production Overseas sales 404.1 263.6 670.1 275.1 138.4 577.1 253.3 116.4 242.7 256.6 207.4 FY2008 1Q (08/4-6) FY2008 4Q (09/1-3) FY2009 1Q (09/4-6)

Motorcycle Automobile Marine & Power products, etc. Total Page 4 Influence of exchange fluctuations included Domestic total -3.7-38.5-0.5-42.7 Overseas total -75.3-215.1-7.8-298.2-85.9 Europe -31.6-109.9-4.0-145.5-31.6 North America -14.1-39.8-1.9-55.8-8.5 Asia -16.4-31.0-0.4-47.8-37.0 Others -13.2-34.4-1.5-49.1-8.8 Total -79.0-253.6-8.3-340.9-85.9 Influence of exchange fluctuations included Consolidated: Net Sales (Year-to-Year Comparison) Excluding Financial Services business -15.5-69.4-1.0-85.9

Consolidated: Operating Income Page 5 33.8 Decreased by 26.9 billion (-79.7%) y-o-y Profit ratio 3.7% 10.4 Profit ratio 1.6% 6.9 Profit ratio 1.2% FY2008 1Q FY2008 4Q FY2009 1Q (08/4-6) (09/1-3) (09/4-6)

Consolidated: Ordinary Income Page 6 Decreased by 32.8 billion (-72.3%) y-o-y 45.4 Profit ratio 5.0% 8.2 Profit ratio 1.2% 12.6 Profit ratio 2.2% FY2008 1Q FY2008 4Q FY2009 1Q (08/4-6) (09/1-3) (09/4-6)

Consolidated: Net Income Page 7 Decreased by 23.9 billion (-91.8%) y-o-y 26.0 Profit ratio 2.9% 5.8 Profit ratio 0.9% 2.1 Profit ratio 0.4% FY2008 1Q FY2008 4Q FY2009 1Q (08/4-6) (09/1-3) (09/4-6)

Consolidated: Factors of Change in Operating Income Page 8 100 Decrease of Cost reduction +2.1 80 Decrease of R&D expenses +4.8 60 Decrease of operatin g expenses, etc. +52.3 depreciation +9.0 Change in sales, model mix, etc. -73.3 40 20 0 FY2008 1Q Operating income 33.8 Factor of increase (+68.2) Operating income decrease (-26.9) Factor of decrease (-95.1) Fore ign exchange loss -21.8 FY2009 1Q Operating income 6.9 (Change in sales, model mix, etc. includes influence of raw material +5.1)

Consolidated: Foreign Exchange Rates Page 9 FY2009 1Q (09/4-6) FY2008 1Q (08/4-6) U.S. dollar Euro Others 97 yen 135 yen ー 110 yen 161 yen ー Change -13 yen -26 yen ー ForEX loss -2.7 bln yen -6.0 bln yen -13.1 bln yen Total -21.8 bln yen

Consolidated: Capital Expenditures (including amount of main affiliates) 52.9 1.8 Page 10 SUZUKI Subsidiaries Main affiliates 28.7 22.4 36.8 4.2 18.4 14.2 27.7 2.3 15.7 9.7 FY2008 1Q FY2008 4Q FY2009 1Q (08/4-6) (09/1-3) (09/4-6)

Consolidated: Depreciation, R&D Expenses, Interest-Bearing Debt Page 11 720.1 38.3 Financial Services 92.5 included 29.3 24.3 19.5 430.5 Depreciation R&D expenses Interest-bearing debt FY2008 1Q FY2009 1Q FY2008 1Q FY2009 1Q (08/4-6) (09/4-6) (08/4-6) (09/4-6) FY2008 1Q FY2009 1Q (08/6) (09/6)

Consolidated:Cash Flows Page 12 Operating activities +53.8 Investment activities -24.3 Financing activities +31.9 Others +4.0 At beginning of FY2009 427.8 Free cash flow 29.5 Cash and cash equivalents Increased by 65.4 At end of FY2009 1Q 493.2

Consolidated:Cash Flows Page 13 09/4~6 09/1~3 Change 08/4~6 Change (Billion Yen) (A) (B) (A)-(B) (C) (A)-(C) Operating activities 53.8 22.7 +31.1 89.2-35.4 Investment activities -24.3-66.9 +42.6-70.3 +46.0 Free cash flow 29.5-44.2 +73.7 18.9 +10.6 Financing activities 31.9 262.5-230.6-29.2 +61.1 Others 4.0-10.0 +14.0-2.8 +6.8 Total amount of change +65.4 +208.3-142.9-13.1 +78.5

Consolidated: Business Segment Page 14 19.4 159.8 731.2 Net sales 20.3 15.3 81.8 586.9 15.0 12.0 80.9 489.2 Financial Services Marine & Power products, etc. Motorcycle Automobile 3.1 5.9 24.8 Operating income Motorcycle 0.9 1.2 16.9-7.0 Financial Services 0.9 1.3 7.0-2.9 FY2008 1Q FY2008 4Q FY2009 1Q FY2008 1Q FY2008 4Q FY2009 1Q (08/4-6) (09/1-3) (09/4-6) (08/4-6) (09/1-3) (09/4-6)

159.8 Consolidated: Business Segment - Motorcycle Page 15 Net sales 81.8 80.9 5.9 Operating income ー 7.0-2.9 FY2008 1Q FY2008 4Q FY2009 1Q (08/4-6) (09/1-3) (09/4-6)

Consolidated: Business Segment - Automobile Page 16 731.2 Net sales 586.9 489.2 24.8 Operating income 16.9 7.0 FY2008 1Q FY2008 4Q FY2009 1Q (08/4-6) (09/1-3) (09/4-6)

Consolidated: Business Segment - Marine and Power products, etc. Page 17 19.4 15.3 Net sales 12.0 3.1 Operating income 1.2 1.3 FY2008 1Q FY2008 4Q FY2009 1Q (08/4-6) (09/1-3) (09/4-6)

Consolidated: Geographical Segment Page 18 22.9 212.3 101.5 219.5 528.7 Net sales 17.1 14.1 183.5 35.0 177.3 122.3 47.1 109.3 400.7 331.0 Others Asia North America Europe Japan Operating income 18.2 3.7-3.3-14.8 1.8-2.0-4.2 FY2008 1Q FY2008 4Q FY2009 1Q FY2008 1Q FY2008 4Q FY2009 1Q (08/4-6) (09/1-3) (09/4-6) (08/4-6) (09/1-3) (09/4-6) 0.8 8.4 1.9-3.2 11.1 0.4 11.2 北米 -1.2

528.7 Consolidated: Geographical Segment - Japan Page 19 Net sales 400.7 331.0 18.2 Operating income ー 3.3-2.0 FY2008 1Q FY2008 4Q FY2009 1Q (08/4-6) (09/1-3) (09/4-6)

219.5 Consolidated: Geographical Segment - Europe Page 20 Net sales 122.3 109.3 1.9 3.7 1.8 Operating income FY2008 1Q FY2008 4Q FY2009 1Q (08/4-6) (09/1-3) (09/4-6)

101.5 Consolidated: Geographical Segment - North America Page 21 Net sales 35.0 47.1 Operating income ー 3.2 ー 4.2 ー 14.8 FY2008 1Q FY2008 4Q FY2009 1Q (08/4-6) (09/1-3) (09/4-6)

212.3 Consolidated: Geographical Segment - Asia Page 22 183.5 177.3 Net sales 8.4 11.1 11.2 Operating income FY2008 1Q FY2008 4Q FY2009 1Q (08/4-6) (09/1-3) (09/4-6)

Consolidated: Geographical Segment - Others Page 23 22.9 Net sales 17.1 14.1 0.8 Operating income ー 1.2 0.4 FY2008 1Q FY2008 4Q FY2009 1Q (08/4-6) (09/1-3) (09/4-6)

Consolidated: Number of Consolidated subsidiaries, Equity method affiliates, Employees Page 24 140 139 52,944 51,894 37 37 Consolidated subsidiaries Equity method affiliates Employees FY2008 1Q FY2009 1Q FY2008 1Q FY2009 1Q FY2008 1Q FY2009 1Q (08/6) (09/6) (08/6) (09/6) (08/6) (09/6)

Consolidated: Inventory Page 25 Net sales Inventory Overseas inventory included (07/10-12) (08/1-3) (08/4-6) (08/7-9) (08/10-12) (09/1-3) (09/4-6) 849.9 469.1 (298.6) 923.7 (+73.8) 440.8 910.4 (-13.3) 398.3 809.5 (-100.9) 385.0 614.8 (-194.7) 412.8 (311.9) +13.3 (279.7) -32.2 (255.2) (223.2) -24.5-32.0 670.1 (+55.3) 324.5 (193.3) -29.9 577.1 (-93.0) 303.6 (184.8) -8.5 07/12 08/3 08/6 08/9 08/12 09/3 09/6

Consolidated: FY2009 Forecast (Unchanged from original forecast) Lower earnings on lower sales Page 26 FY2009 Forecast FY2008 Actual Net sales 2,300.0 3,004.8 Operating income 10.0 76.9 Ordinary income 20.0 79.7 Net income 5.0 27.4 ForEX rate US dollar 90 yen 101 yen Euro 115 yen 144 yen

Production: Motorcycle Page 27 Domestic production Overseas production 3,305 Unit: thousands -12.7% 2,885 897 826 616 561 619 576 2,993 2,602 71 55 43 FY2008 1Q FY2008 4Q FY2009 1Q (08/4-6) (09/1-3) (09/4-6) 312 283 FY2008 FY2009 Forecast

Sales: Motorcycle Page 28 Domestic sales Overseas sales Unit: thousands 991 3,350-10.2% 3,007 953 648 622 711 687 3,222 2,890 38 27 24 FY2008 1Q FY2008 4Q FY2009 1Q (08/4-6) (09/1-3) (09/4-6) 128 117 FY2008 FY2009 Forecast

Production: Automobile Page 29 Domestic production Overseas production 2,494 Unit: thousands -7.7% 2,301 683 373 310 575 343 233 564 354 210 1,355 1,139 1,348 953 FY2008 1Q FY2008 4Q FY2009 1Q FY2008 FY2009 (08/4-6) (09/1-3) (09/4-6) Forecast

Sales: Automobile Page 30 Domestic sales Overseas sales 2,306 Unit: thousands -5.0% 2,190 618 611 541 1,641 1,535 456 419 400 161 192 141 665 655 FY2008 1Q FY2008 4Q FY2009 1Q FY2008 FY2009 (08/4-6) (09/1-3) (09/4-6) Forecast

FY2009 First Quarter Financial Results SUZUKI MOTOR CORPORATION

Caution with respect to Forward-Looking Statements The forward-looking statements of this fiscal year mentioned in this document are calculated based on currently available information and assumptions and contain risks and uncertainty. Please note that the actual results may greatly vary by the changes of various factors. Those factors, which may influence the actual results, include economic conditions and the trend of demand in major markets and the fluctuation of foreign exchange rate. (mainly Yen /US dollar rate, Yen/Euro rate). This document is an English translation of the original Japanese document. If there are any discrepancies between this document and the original Japanese document, the original Japanese document prevails.